ADME Toxicology Testing Market Report Scope & Overview:
The ADME toxicology testing market size was valued at USD 6.64 billion in 2025E and is projected to reach USD 14.40 billion by 2033, growing at a CAGR of 10.17% during 2026-2033.
The global ADME toxicology testing market trend is being strongly driven by rising drug development activities. Increasing discovery of new molecular entities (NMEs), biologics, and gene therapies requires extensive preclinical ADME/Tox studies to ensure safety and efficacy. Additionally, the outsourcing trend to CROs is accelerating market growth, as pharmaceutical and biotechnology companies increasingly seek cost-efficient, specialized testing solutions, aligning with the trend of faster, streamlined preclinical development.
For instance, in July 2024, WuXi AppTec reported biologics ADME/Tox studies accounted for 42% of preclinical workload, reflecting the market growth trend.
Market Size and Forecast:
-
Market Size in 2025: USD 6.64 billion
-
Market Size by 2033: USD 14.40 billion
-
CAGR: 10.17% from 2026 to 2033
-
Base Year: 2025
-
Forecast Period: 2026–2033
-
Historical Data: 2022–2024
ADME Toxicology Testing Market Trends
-
Rising drug discovery and preclinical research activities are driving global demand for ADME Toxicology Testing services.
-
Outsourcing to Contract Research Organizations (CROs) is increasing adoption of specialized ADME/Tox testing solutions by pharmaceutical and biotechnology companies.
-
Advancements in in vitro, organ-on-chip, and AI-based predictive toxicology platforms are supporting faster and more accurate preclinical assessments.
-
Growing biologics and gene therapy pipelines are creating demand for customized ADME/Tox testing and specialized metabolic studies.
-
Increasing investments by pharmaceutical companies and government grants are fueling preclinical R&D and new ADME/Tox method development.
-
Adoption of FDA, EMA, and ICH-compliant testing protocols is enhancing regulatory acceptance, safety, and quality assurance in drug development.
-
Expansion of CRO services in emerging regions, including Asia-Pacific, offers cost-effective preclinical solutions and new growth opportunities for market players.
U.S. ADME Toxicology Testing Market Insights
The U.S. ADME toxicology testing market size was valued at USD 2.18 billion in 2025E and is projected to reach USD 4.69 billion by 2033, growing at a CAGR of 10.10% during 2026-2033. The U.S. ADME toxicology testing market analysis shows dominance due to its high pharmaceutical and biotechnology R&D spending, enabling extensive preclinical ADME/Tox studies. Additionally, the strong presence of leading CROs, including Charles River and Covance, drives market growth, as outsourcing to these specialized organizations ensures speed, quality, and regulatory compliance, reinforcing the US’s leadership in global ADME/Tox testing.
ADME Toxicology Testing Market Growth Drivers:
-
Outsourcing to Contract Research Organizations Driving ADME Toxicology Testing Consumption Growth
Outsourcing to Contract Research Organizations (CROs) is a major driver of the ADME toxicology testing market. Pharmaceutical and biotechnology companies increasingly rely on CROs for preclinical ADME/Tox studies to reduce costs, access specialized expertise, and accelerate development timelines. This trend allows companies to focus on core research while ensuring high-quality, regulatory-compliant testing, fueling global market growth.
For instance, in January 2025, over 30% of their ADME/Tox workload now comes from US-based pharma outsourcing contracts, indicating sustained market reliance on CROs.
ADME Toxicology Testing Market Restraints:
-
Complexity of Biologics and Novel Therapies Limits Market Expansion Globally
The complexity of biologics and novel therapies is a key restraint for the ADME toxicology testing market growth. Emerging treatments, including gene therapies, cell therapies, and biologics, require highly specialized ADME/Tox testing protocols, increasing both time and operational costs. This complexity can slow adoption, particularly for smaller companies, potentially limiting the overall expansion of the global market.
ADME Toxicology Testing Market Opportunities:
-
Adoption of Advanced In Vitro and In Silico Models Creates Growth Opportunities for the ADME Toxicology Testing Market
The adoption of advanced in vitro and in silico models presents a significant opportunity for the ADME toxicology testing market. Techniques including organ-on-chip systems, 3D cell cultures, and AI-driven predictive toxicology enable faster, more accurate, and cost-effective preclinical testing. These innovations reduce reliance on traditional animal models, improve early-stage safety predictions, and allow pharmaceutical and biotechnology companies to streamline drug development, driving market growth and technological advancement.
For instance, in July 2024, Frontage Laboratories reported that 25% of their ADME/Tox projects utilize AI-based predictive toxicology tools, improving the speed and accuracy of preclinical studies.Top of Form
ADME Toxicology Testing Market Segmentation Analysis
-
By technology, cell culture led the ADME toxicology testing market with a 44.82% share in 2025e, while high throughput is the fastest-growing segment with a CAGR of 10.81%.
-
By application, the systemic toxicity dominated the market with a 54.88% share in 2025e, whereas the renal toxicity segment is expected to grow fastest with a CAGR of 10.96%.
-
By method, cellular assay led the market with a 45.84% share in 2025e, while biochemical assay platforms are registering the fastest growth with a CAGR of 10.69%.
-
By end-user, pharmaceutical & biotechnology companies held 45.86%share in 2025e, while contract research organizations (CROs) are growing the fastest with a CAGR of 10.49%.
By Technology, Cell Culture Lead Market While High Throughput Register Fastest Growth
The cell culture segment dominated the ADME toxicology testing market with a revenue share of about 44.82% in 2025E, due to its high-throughput, cost-effective, and predictive in vitro capabilities, driven by rising drug discovery, biologics development, and adoption of 3D and organ-on-chip technologies. The high throughput segment will grow at the highest CAGR of nearly 10.81% CAGR between 2026 and 2033, due to increasing demand for rapid, large-scale compound screening, efficiency in drug discovery, and adoption of automated, AI-driven, and predictive toxicology technologies.
By Application, Systemic Toxicity Dominates While Renal Toxicity Shows Rapid Growth
The systemic toxicity segment was estimated to be the largest revenue generator with an approximate 54.88% of the total market share in 2025E, as it evaluates overall drug safety across organs, driven by stringent regulatory requirements, rising biologics development, growing preclinical testing demand, and the need to prevent late-stage clinical failures, ensuring safer therapeutics. For instance, the renal toxicity segment is anticipated to be the fastest growing with a CAGR of around 10.96%, by 2026-2033, due to increasing incidence of kidney-related drug side effects, rising biologics and small-molecule development, and demand for early, predictive preclinical toxicity assessment.
By Method, Cellular Assay Lead While Biochemical Assay Platforms Register Fastest Growth
The cellular assay segment accounted for the highest share of revenues in the ADME toxicology testing market at 45.84% in the year 2025E, owing to it enable precise, high-throughput evaluation of drug effects at the cellular level, driven by growing drug discovery, biologics development, adoption of 3D cultures, and demand for predictive, cost-effective preclinical testing. While the biochemical assay platforms segment is expected to achieve the fastest CAGR of approximately 10.69% during the predicted period from 2026-2033, due to increasing demand for rapid enzyme and protein interaction analysis, rising small-molecule drug development, and adoption of high-throughput, automated preclinical testing technologies.
By End-user, Pharmaceutical & Biotechnology Companies Lead While Contract Research Organizations (CROs) Grow Fastest
The pharmaceutical & biotechnology companies segment accounted for the largest share of the ADME toxicology testing market at around 45.86%in 2025E, as they conduct extensive drug discovery and preclinical studies, driven by rising R&D investments, biologics development, regulatory compliance requirements, and the need for accurate, predictive ADME/Tox testing. The contract research organizations (CROs) segment will have the highest CAGR of nearly 10.49% during 2026–2033, due to increasing outsourcing by pharmaceutical and biotech companies, cost-efficiency, access to specialized expertise, and demand for faster, high-quality preclinical testing services.Top of Form
ADME Toxicology Testing Market Regional Analysis:
North America ADME Toxicology Testing Market Insights
North America dominates the ADME toxicology testing market with a market share of 43.60% 2025E, due to its large concentration of pharmaceutical and biotechnology companies, high R&D expenditure, and advanced preclinical infrastructure. The presence of leading CROs, widespread adoption of cutting-edge technologies including organ-on-chip, 3D cell cultures, and AI-based predictive toxicology, and stringent regulatory frameworks including FDA guidelines further drive market dominance, ensuring high-quality, compliant ADME/Tox testing and sustained regional growth.
U.S. ADME Toxicology Testing Market Insights
The U.S. ADME toxicology testing market analysis shows dominance due to its high pharmaceutical and biotechnology R&D spending, enabling extensive preclinical ADME/Tox studies. Additionally, the strong presence of leading CROs, including Charles River and Covance.
Asia-Pacific ADME Toxicology Testing Market Insights
Asia-Pacific is the fastest-growing region in the ADME toxicology testing market, registering a CAGR of 11.10% over the forecast period, due to increasing pharmaceutical and biotechnology R&D activities, cost-effective preclinical testing, and the expanding presence of Contract Research Organizations (CROs) in countries including China and India. Rising adoption of advanced technologies including organ-on-chip, 3D cell cultures, and AI-driven predictive toxicology, along with supportive government initiatives and growing biologics and gene therapy pipelines, is fueling demand, making the region a key driver of global market growth.
China ADME Toxicology Testing Market Insights
China dominates the Asia-Pacific ADME toxicology testing market due to its large pharmaceutical R&D investments, extensive CRO infrastructure, cost-effective preclinical testing services, and government support, attracting global outsourcing and accelerating the adoption of advanced ADME/Tox technologies.Top of Form
Europe ADME Toxicology Testing Market Insights
Europe is the second-dominating region in the ADME toxicology testing market due to its strong pharmaceutical and biotechnology sector, high R&D expenditure, and well-established Contract Research Organizations (CROs). Strict regulatory frameworks from the EMA and ICH drive demand for compliant ADME/Tox studies. Additionally, growing adoption of advanced in vitro and in silico technologies, along with the expansion of biologics and gene therapy pipelines, supports preclinical testing growth, making Europe a key market contributor.
Germany ADME Toxicology Testing Market Insights
Germany dominates the European ADME toxicology testing market due to its robust pharmaceutical and biotech industry, advanced preclinical research infrastructure, strong regulatory compliance with EMA guidelines, and adoption of innovative technologies, positioning it as a key regional hub.
Latin America (LATAM) and Middle East & Africa (MEA) ADME Toxicology Testing Market Insights
The Middle East & Africa and Latin America are emerging regions in the ADME toxicology testing market. Growth is driven by increasing pharmaceutical and biotech R&D, rising outsourcing to local Contract Research Organizations (CROs), and cost-effective preclinical testing services. Government initiatives supporting healthcare innovation and regulatory compliance, along with the gradual adoption of advanced in vitro and predictive toxicology technologies, are further expanding market opportunities in these regions, positioning them for steady growth.
ADME Toxicology Testing Market Competitive Landscape:
Covance is a global contract research organization providing comprehensive ADME and toxicology testing services. With expertise across small molecules and biologics, it supports preclinical and clinical drug development. Its extensive laboratory network and regulatory compliance focus make it a leader in high-quality, end-to-end ADME/Tox solutions globally.
-
In March 2024, expanded US toxicology lab; October 2025: Launched AI-driven predictive toxicology platform, enhancing preclinical ADME/Tox study speed and accuracy.
Eurofins Scientific offers extensive ADME/Toxicology services through its network of laboratories. Specializing in in vitro and in vivo testing, it supports pharmaceutical, biotech, and chemical industries. The company emphasizes innovative testing methods, regulatory compliance, and rapid service delivery, driving global adoption in preclinical safety assessment.
-
In June 2024, opened Singapore ADME/Tox lab for biologics and gene therapies; February 2025: Introduced high-throughput 3D cell culture services, improving predictive accuracy.
Lonza provides integrated preclinical ADME/Toxicology testing and biopharmaceutical development services. Known for its biologics and cell-based testing expertise, the company delivers scalable, high-quality solutions. Its global presence, regulatory alignment, and focus on cutting-edge in vitro models make it a key player in ADME/Tox testing.
-
In July 2024, expanded in vitro ADME/Tox portfolio with organ-on-chip integration; January 2025: Partnered with global pharma for customized preclinical ADME/Tox solutions.
ADME Toxicology Testing Market Key Players:
Some of the ADME toxicology testing market Companies are:
-
Covance Inc.
-
Eurofins Scientific
-
Lonza Group Ltd.
-
PRA Health Sciences
-
WuXi AppTec
-
Thermo Fisher Scientific
-
Envigo
-
Frontage Laboratories, Inc.
-
MPI Research
-
Absorption Systems, LLC
-
ChemPartner
-
PharmaLegacy Labs
-
Altasciences
-
Covance Preclinical Services
-
BioDuro
-
Toxikon
-
Corporation
-
Absorption
-
Systems
-
SRI
-
Biosciences
-
ChemPartner
-
Global
-
Services
-
Frontage
-
Global
-
Services
| Report Attributes | Details |
|---|---|
| Market Size in 2025 | USD 6.64 Billion |
| Market Size by 2033 | USD 14.40 Billion |
| CAGR | CAGR of 10.17 % From 2026 to 2033 |
| Base Year | 2025 |
| Forecast Period | 2026-2033 |
| Historical Data | 2022-2024 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS Technology) • By Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Toxicities) • By Method (Cellular Assay, Biochemical Assay, In-Silica, Ex vivo) • By End-user (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes, Regulatory & Government Agencies) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
| Company Profiles | Covance Inc., Eurofins Scientific, Lonza Group Ltd., PRA Health Sciences, WuXi AppTec, Thermo Fisher Scientific, Envigo, Frontage Laboratories, Inc., MPI Research, Absorption Systems, LLC, ChemPartner, PharmaLegacy Labs, Altasciences, Covance Preclinical Services, BioDuro, Toxikon, Corporation, Absorption, Systems, SRI, Biosciences, ChemPartner, Global, Services, Frontage, Global, Services and other players. |
Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2033
2.3 Market Size & Forecast, By Segmentation, 2022–2033
2.3.1 Market Size By Technology
2.3.2 Market Size By Application
2.3.3 Market Size By Method
2.3.4 Market Size By End-user
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Biochemical Assay/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Regulatory & Compliance Metrics
4.1 Number of FDA, EMA, and ICH approvals for ADME/Tox studies annually
4.2 Average time (months) for regulatory approval of preclinical study protocols
4.3 Regulatory submission success rate (%)
4.4 Percentage of studies meeting GLP/GCP compliance
4.5 Frequency of regulatory audits/inspections per year
4.2 Preclinical R&D Metrics
4.2.1 Number of compounds tested annually in ADME/Tox studies
4.2.2 Average duration (weeks/months) to complete ADME/Tox testing per compound
4.2.3 Failure rate (%) of compounds in preclinical studies
4.2.4 Share (%) of studies conducted in-house vs. outsourced to CROs
4.2.5 Average staff count per preclinical study team
4.3 Technology Adoption Statistics
4.3.1 Share (%) of in vitro, in vivo, and in silico ADME/Tox testing methods
4.3.2 Growth rate (%) of organ-on-chip and 3D cell culture adoption
4.3.3 Adoption rate (%) of AI-based predictive toxicology platforms
4.3.4 Percentage (%) of high-throughput screening (HTS) implementation
4.3.5 Regional penetration (%) of microfluidics and lab-on-chip technologies
4.4 Investment & Funding Data
4.4.1 Number of investments or funding rounds in ADME/Tox CROs/biotech firms
4.4.2 Total R&D spend ($ Million/Billion) on ADME/Tox testing per year
4.4.3 Share (%) of government grants vs. private investments in preclinical research
4.4.4 Number of mergers, acquisitions, or partnerships in ADME/Tox annually
4.4.5 Average deal value ($ Million/Billion) per transaction
5. ADME Toxicology Testing Market Segmental Analysis & Forecast, By Technology, 2022 – 2033, Value (USD Billion)
5.1 Introduction
5.2 Cell Culture
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2033
5.3 High Throughput
5.4 Molecular Imaging
5.5 OMICS Technology
6. ADME Toxicology Testing Market Segmental Analysis & Forecast, By Application, 2022 – 2033, Value (USD Billion)
6.1 Introduction
6.2 Systemic Toxicity
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2033
6.3 Renal Toxicity
6.4 Hepatotoxicity
6.5 Neurotoxicity
6.6 Other Toxicities
7. ADME Toxicology Testing Market Segmental Analysis & Forecast, By Method, 2022 – 2033, Value (USD Billion)
7.1 Introduction
7.2 Cellular Assay
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2033
7.3 Biochemical Assay
7.4 In-Silica
7.4 Ex vivo
8. ADME Toxicology Testing Market Segmental Analysis & Forecast, By End-user, 2022 – 2033, Value (USD Billion)
8.1 Introduction
8.2 Pharmaceutical & biotechnology companies
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022 – 2033
8.3 Contract Research Organizations (CRO)
-
- Academic and research organizations
8.5 Regulatory & Government Agencies
9. ADME Toxicology Testing Market Segmental Analysis & Forecast By Region, 2022 – 2033, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.2.3 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.2.4 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.2.5 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.2.6 ADME Toxicology Testing Market Size & Forecast, By Country, 2022 – 2033
9.2.6.1 USA
9.2.6.1.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.2.6.1.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.2.6.1.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.2.6.1.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.2.6.2 Canada
9.2.6.2.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.2.6.2.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.2.6.2.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.2.6.2.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.3 Europe
9.3.1 Key Trends
9.3.2 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.3.3 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.3.4 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.3.5 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.3.6 ADME Toxicology Testing Market Size & Forecast, By Country, 2022 – 2033
9.3.6.1 Germany
9.3.6.1.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.3.6.1.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.3.6.1.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.3.6.1.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.3.6.2 UK
9.3.6.2.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.3.6.2.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.3.6.2.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.3.6.2.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.3.6.3 France
9.3.6.3.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.3.6.3.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.3.6.3.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.3.6.3.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.3.6.4 Italy
9.3.6.4.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.3.6.4.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.3.6.4.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.3.6.4.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.3.6.5 Spain
9.3.6.5.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.3.6.5.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.3.6.5.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.3.6.5.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.3.6.6 Russia
9.3.6.6.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.3.6.6.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.3.6.6.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.3.6.6.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.3.6.7 Poland
9.3.6.7.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.3.6.7.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.3.6.7.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.3.6.7.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.3.6.8 Rest of Europe
9.3.6.8.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.3.6.8.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.3.6.8.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.3.6.8.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.4.3 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.4.4 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.4.5 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.4.6 ADME Toxicology Testing Market Size & Forecast, By Country, 2022 – 2033
9.4.6.1 China
9.4.6.1.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.4.6.1.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.4.6.1.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.4.6.1.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.4.6.2 India
9.4.6.2.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.4.6.2.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.4.6.2.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.4.6.2.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.4.6.3 Japan
9.4.6.3.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.4.6.3.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.4.6.3.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.4.6.3.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.4.6.4 South Korea
9.4.6.4.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.4.6.4.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.4.6.4.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.4.6.4.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.4.6.5 Australia
9.4.6.5.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.4.6.5.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.4.6.5.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.4.6.5.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.4.6.6 ASEAN Countries
9.4.6.6.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.4.6.6.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.4.6.6.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.4.6.6.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.4.6.7.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.4.6.7.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.4.6.7.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.5 Latin America
9.5.1 Key Trends
9.5.2 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.5.3 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.5.4 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.5.5 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.5.6 ADME Toxicology Testing Market Size & Forecast, By Country, 2022 – 2033
9.5.6.1 Brazil
9.5.6.1.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.5.6.1.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.5.6.1.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.5.6.1.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.5.6.2 Argentina
9.5.6.2.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.5.6.2.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.5.6.2.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.5.6.2.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.5.6.3 Mexico
9.5.6.3.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.5.6.3.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.5.6.3.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.5.6.3.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.5.6.4 Colombia
9.5.6.4.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.5.6.4.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.5.6.4.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.5.6.4.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.5.6.5 Rest of Latin America
9.5.6.5.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.5.6.5.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.5.6.5.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.5.6.5.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.6.3 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.6.4 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.6.5 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.6.6 ADME Toxicology Testing Market Size & Forecast, By Country, 2022 – 2033
9.6.6.1 UAE
9.6.6.1.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.6.6.1.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.6.6.1.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.6.6.1.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.6.6.2 Saudi Arabia
9.6.6.2.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.6.6.2.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.6.6.2.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.6.6.2.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.6.6.3 Qatar
9.6.6.3.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.6.6.3.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.6.6.3.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.6.6.3.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.6.6.4 Egypt
9.6.6.4.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.6.6.4.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.6.6.4.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.6.6.4.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.6.6.5 South Africa
9.6.6.5.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.6.6.5.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.6.6.5.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.6.6.5.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 ADME Toxicology Testing Market Size & Forecast, By Technology, 2022 – 2033
9.6.6.6.2 ADME Toxicology Testing Market Size & Forecast, By Application, 2022 – 2033
9.6.6.6.3 ADME Toxicology Testing Market Size & Forecast, By Method, 2022 – 2033
9.6.6.6.4 ADME Toxicology Testing Market Size & Forecast, By End-user, 2022 – 2033
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2025
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2025
10.3 Market Share Analysis, 2025
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Covance Inc.
10.6.1.1 Company overview & snapshot
10.6.1.2 Product/service portfolio
10.6.1.3 Key company financials
10.6.1.4 SWOT analysis
10.6.2 Eurofins Scientific
10.6.3 Lonza Group Ltd.
10.6.4 PRA Health Sciences
10.6.5 WuXi AppTec
10.6.6 Thermo Fisher Scientific
10.6.7 Envigo
10.6.8 Frontage Laboratories, Inc.
10.6.9 MPI Research
10.6.10 Absorption Systems, LLC
10.6.11 ChemPartner
10.6.12 PharmaLegacy Labs
10.6.13 Altasciences
10.6.14 Covance Preclinical Services
10.6.15 BioDuro
10.6.16 Toxikon Corporation
10.6.17 Absorption Systems
10.6.18 SRI Biosciences
10.6.19 ChemPartner Global Services
10.6.20 Frontage Global Services
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figure
Key Segments:
By Technology
-
Cell Culture
-
High Throughput
-
Molecular Imaging
-
OMICS Technology
By Application
-
Systemic Toxicity
-
Renal Toxicity
-
Hepatotoxicity
-
Neurotoxicity
-
Other Toxicities
By Method
-
Cellular Assay
-
Biochemical Assay
-
In-Silica
-
Ex vivo
By End-User
-
Pharmaceutical & Biotechnology Companies
-
Contract Research Organizations (CROs)
-
Academic & Research Institutes
-
Regulatory & Government Agencies
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
